OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)

Q4 2013 13F Holdings Report, Stock Holdings

Signature - Title
Sal DiGangi - CCO
Location
Chicago, IL
Holdings as of
31 Dec 2013
Value $
$5,392,533,000
Num holdings
340
Filing time
13 Feb 2014, 11:22:12 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included TERADYNE, HUM, MYLAN IN, LIFE, and NLSN. Confidential Treatment Requested (one or more holding(s) omitted).
Next filing
Q1 2014 - 14 May 2014
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Confidential Treatment Requested. (The Manager has omitted from this public Form 13F one or more holding(s) for which it is requesting confidential treatment from the U.S. Securities and Exchange Commission pursuant to section 13(f) of the Exchange Act and rule 24b-2 thereunder)

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Sal DiGangi CCO New York, New York 13 Feb 2014